Microba Life Sciences, is empowering global consumer goods company Unilever to explore links between sleep and the human gut.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
The partnership's first clinical trial will determine if a new treatment can restore beneficial gut microbiome species and improve symptoms.
Bringing Microba’s world-leading metagenomic sequencing and bioinformatics together with Holobiome’s promising microbiome therapeutic pipeline.
Research study at Curtin University examining possible links between infant gut microbiome composition and the development of allergies.
Microba have partnered with the Microbiome Research Centre (MRC) to power new gut microbiome research.
Microba will join forces with other internationally-renowned research entities on a groundbreaking project to tackle antimicrobial resistance.